Cresco Labs (CRLBF) Other Operating Expenses (2020 - 2025)
Cresco Labs (CRLBF) posted Other Operating Expenses of $101.9 million for Q4 2025, up 7175.14% on a QoQ basis from $1.4 million in Q3 2025, and up 3212.84% year-over-year from $3.1 million in Q4 2024.
Cresco Labs (CRLBF) Other Operating Expenses (2020 - 2025) Analysis & Trends
Cresco Labs' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $101.9 million for Q4 2025.
- Quarterly Other Operating Expenses rose 3212.84% year-over-year to $101.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $102.4 million (up 263.95% YoY) and the FY2025 annual result came in at $105.1 million, up 269.71% from the prior year.
- Other Operating Expenses was $101.9 million for Q4 2025 at Cresco Labs, up from $1.4 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $151.0 million in Q4 2022 and bottomed at -$59.5 million in Q2 2024.
- A 5-year average of $10.0 million and a median of $50000.0 in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2021 — Other Operating Expenses plunged 17531.51% — and 2025, when it surged 28100.0%.
- Cresco Labs' Other Operating Expenses stood at $10.9 million in 2021, then jumped by 1283.83% to $151.0 million in 2022, then tumbled by 99.97% to $50000.0 in 2023, then plunged by 6644.0% to -$3.3 million in 2024, then jumped by 3212.84% to $101.9 million in 2025.
- Business Quant data shows CRLBF's Other Operating Expenses at $101.9 million in Q4 2025, $1.4 million in Q3 2025, and -$836000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.85 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | -836,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | -3.27 Mn |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -59.51 Mn |
| Mar 31, 2024 | 856,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 329,000.00 |
| Jun 30, 2023 | 402,000.00 |
| Dec 31, 2022 | 150.99 Mn |
| Mar 31, 2022 | -6.77 Mn |
| Dec 31, 2021 | 10.91 Mn |
| Sep 30, 2021 | -1.74 Mn |
| Jun 30, 2021 | -12.73 Mn |
| Mar 31, 2021 | -12.34 Mn |
| Dec 31, 2020 | 18.47 Mn |
| Sep 30, 2020 | 354,000.00 |
| Jun 30, 2020 | 73,000.00 |